Therapy-related acute promyelocytic leukemia (t-APL) is rare and often linked to previous treatment with alkylating agents or topoisomerase II inhibitors. This report describes three cases of t-APL ...

Researchers have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately detects the presence of ...

Rapid blood cancer diagnostics enable faster decision-making, potentially saving lives by providing quicker, more accurate ...

Blood cancer is not always fatal and advancements in treatment offer significant hope. Misconceptions exist, such as it being ...

As the Buffalo Bills look for additional production from their receiving corps, they should be interested in an underrated ...

Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions.

New technology that rapidly and simply detects disease-specific molecular alterations in two forms of leukemia could give ...

After hours: October 11 at 4:10 PM EDT Loading Chart for SYRS ...

the MND pattern mainly originates from autoantibodies directed to the Sp100 and the promyelocytic leukemia (PML) protein, antigens that are both localized in the NB. Of potential clinical ...

AIH type 3 is serologically defined by the presence of SLA/LP autoantibodies. However, 74% of patients also have other serological markers of autoimmunity, including SMA and AMA. AIH type 3 has a ...